Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.

Conant JL, Peng Z, Evans MF, Naud S, Cooper K.

J Clin Pathol. 2011 Dec;64(12):1088-92. doi: 10.1136/jclinpath-2011-200216. Epub 2011 Oct 16.

PMID:
22003062
2.

Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.

Ipekci T, Ozden F, Unal B, Saygin C, Uzunaslan D, Ates E.

Pathol Oncol Res. 2015 Sep;21(4):1209-16. doi: 10.1007/s12253-015-9958-z. Epub 2015 Jun 4.

PMID:
26037169
3.

Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.

J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.

PMID:
23928229
4.

Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor Snail.

Gwin K, Buell-Gutbrod R, Tretiakova M, Montag A.

Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):526-31. doi: 10.1097/PAI.0b013e3181e8d54b.

PMID:
20697265
5.

MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.

Gnemmi V, Bouillez A, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Villers A, Vindrieux D, Cauffiez C, Van Seuningen I, Bernard D, Leroy X, Aubert S, Perrais M.

Cancer Lett. 2014 May 1;346(2):225-36. doi: 10.1016/j.canlet.2013.12.029. Epub 2013 Dec 30.

PMID:
24384091
6.

Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.

Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mukai M, Okada Y.

Lab Invest. 2011 Oct;91(10):1443-58. doi: 10.1038/labinvest.2011.111. Epub 2011 Aug 1.

7.

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.

Galván JA, Astudillo A, Vallina A, Fonseca PJ, Gómez-Izquierdo L, García-Carbonero R, González MV.

Am J Clin Pathol. 2013 Jul;140(1):61-72. doi: 10.1309/AJCPIV40ISTBXRAX.

PMID:
23765535
8.

ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion.

Papanikolaou S, Bravou V, Gyftopoulos K, Nakas D, Repanti M, Papadaki H.

Histopathology. 2010 May;56(6):799-809. doi: 10.1111/j.1365-2559.2010.03556.x.

PMID:
20546345
9.

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC.

Hepatology. 2009 Nov;50(5):1464-74. doi: 10.1002/hep.23221.

PMID:
19821482
10.

The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma.

O'Mahony FC, Faratian D, Varley J, Nanda J, Theodoulou M, Riddick AC, Harrison DJ, Stewart GD.

PLoS One. 2012;7(2):e31557. doi: 10.1371/journal.pone.0031557. Epub 2012 Feb 21.

11.

Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.

Luo W, Fang W, Li S, Yao K.

Int J Cancer. 2012 Oct 15;131(8):1863-73. doi: 10.1002/ijc.27467. Epub 2012 Mar 15.

12.

Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.

Cao YW, Wan GX, Sun JP, Cui XB, Hu JM, Liang WH, Zheng YQ, Li WQ, Li F.

Kaohsiung J Med Sci. 2015 Feb;31(2):70-6. doi: 10.1016/j.kjms.2014.11.008. Epub 2014 Dec 16.

13.

Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.

Angadi PV, Patil PV, Angadi V, Mane D, Shekar S, Hallikerimath S, Kale AD, Kardesai SG.

Int J Surg Pathol. 2016 Dec;24(8):696-703. Epub 2016 Jun 15.

PMID:
27312520
14.

An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.

McCart Reed AE, Kutasovic JR, Vargas AC, Jayanthan J, Al-Murrani A, Reid LE, Chambers R, Da Silva L, Melville L, Evans E, Porter A, Papadimos D, Thompson EW, Lakhani SR, Simpson PT.

J Pathol. 2016 Mar;238(4):489-94. doi: 10.1002/path.4668. Epub 2016 Feb 1.

PMID:
26510554
15.

Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck.

Zidar N, Gale N, Kojc N, Volavsek M, Cardesa A, Alos L, Höfler H, Blechschmidt K, Becker KF.

Virchows Arch. 2008 Sep;453(3):267-74. doi: 10.1007/s00428-008-0649-y. Epub 2008 Aug 19.

PMID:
18712413
16.

TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.

Kim YH, Kim G, Kwon CI, Kim JW, Park PW, Hahm KB.

Oncol Rep. 2014 Mar;31(3):1380-8. doi: 10.3892/or.2014.2970. Epub 2014 Jan 8.

PMID:
24402192
17.

Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.

Zheng H, Li W, Wang Y, Liu Z, Cai Y, Xie T, Shi M, Wang Z, Jiang B.

Eur J Cancer. 2013 Aug;49(12):2734-46. doi: 10.1016/j.ejca.2013.03.014. Epub 2013 Apr 9.

PMID:
23582741
18.

Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

Huang XY, Zhang C, Cai JB, Shi GM, Ke AW, Dong ZR, Zhang PF, Fan J, Peng BG, Zhou J.

PLoS One. 2014 May 9;9(5):e96860. doi: 10.1371/journal.pone.0096860. eCollection 2014.

19.

Crosstalk between beta-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1/2 pathway.

Zucchini-Pascal N, Peyre L, Rahmani R.

Int J Mol Sci. 2013 Oct 16;14(10):20768-92. doi: 10.3390/ijms141020768.

20.

Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.

Lee YJ, Han HJ.

Am J Physiol Renal Physiol. 2010 May;298(5):F1263-75. doi: 10.1152/ajprenal.00475.2009. Epub 2009 Dec 16.

PMID:
20015942

Supplemental Content

Support Center